Despatch of Scheme Documents

RNS Number:2825F
Virotec International Ld
28 June 2006

                           VIROTEC INTERNATIONAL LTD

28 June 2006


       Transfer of Virotec Group Domicile - Despatch of Scheme Documents

The directors of Virotec International Ltd ('Virotec (Aus)') (AIM: VTI), advise
that further to the prior announcements on 1 June 2006 and 19 June 2006 in
relation to the proposal to effect the change of domicile of the Virotec Group
from Australia to England through a scheme of arrangement under the Australian
Corporations Act 2001 (the 'Proposed Scheme'), the Proposed Scheme documentation
has been sent to shareholders. The Proposed Scheme involves a share-for-share
exchange with Virotec International plc ('Virotec UK'), a company newly
incorporated in England and Wales and established for this purpose.

The Proposed Scheme documentation, which includes an explanatory statement and
an Appendix to the AIM pre-Admission announcement, will be made available for
download from Virotec (Aus)'s website at www.virotec.com and is available on
request by emailing mail@virotec.com or telephoning +617 5530 8014.

An indicative timetable, which is subject to change, is set out below:

First Supreme Court of Queensland Hearing             19 June 2006 (completed)
Despatch of Scheme Documents to shareholders          28 June 2006 (completed)
Meeting of shareholders of Virotec (Aus)              31 July 2006
Second Supreme Court of Queensland Hearing            17 August 2006
Effective Date for Proposed Scheme implementation     17 August 2006
Suspension of Virotec (Aus) from trading on AIM       17 August 2006
Record Date to determine entitlements                 24 August 2006
Cancellation of AIM listing of Virotec (Aus)          30 August 2006
First day of trading of Virotec (UK)                  30 August2006

For further information on the Proposed Scheme please contact Angus Craig,
Company Secretary on +617 5530 8014 or by email at mail@virotec.com, or visit
Virotec's website at www.virotec.com.


This document is issued by Virotec International Ltd (the "Company"), its
contents having been approved solely for the purpose of section 21 of the
Financial Services and Markets Act 2000 by Numis Securities Limited of Cheapside
House, 138 Cheapside, London, United Kingdom EC2V 6LH.  Numis Securities Limited
which is authorised and regulated by the Financial Services Authority, is the
nominated adviser and broker for the Company for the purposes of the AIM Rules.
Its responsibilities as the Company's nominated adviser under the AIM Rules are
owed solely to London Stock Exchange plc and are not owed to the Company, any
director of the Company or to any other person or entity.  No liability
whatsoever is accepted by Numis Securities Limited for the accuracy of any
information or opinions contained in this document or for the omission of any
information from this document.  Numis Securities Limited is acting for the
Company and for no one else and will not be responsible to any other person for
providing the protections afforded to customers of Numis Securities Limited or
for providing advice in connection with the contents of this document or any
matter referred to herein.

Numis Securities Limited may be providing or may have provided within the
previous 12 months, significant advice or investment services in relation to
securities in the Company or a related investment.



                           Virotec International Ltd
                               ABN 81 004 801 398
                                   PO Box 188
                            Sanctuary Cove QLD 4212
                                   Australia
                                www.virotec.com


                      This information is provided by RNS
            The company news service from the London Stock Exchange

END
SOASEASUASMSEEM
Virotec (LSE:VTI)
과거 데이터 주식 차트
부터 12월(12) 2024 으로 1월(1) 2025